相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascade
Shiu-Wen Huang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Dual effects of active ERK in cancer: A potential target for enhancing radiosensitivity
Yinliang Lu et al.
ONCOLOGY LETTERS (2020)
The Innovative Potential of Statins in Cancer: New Targets for New Therapies
Elisabetta Di Bello et al.
FRONTIERS IN CHEMISTRY (2020)
STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway
Maria Anele Romeo et al.
FRONTIERS IN ONCOLOGY (2020)
Inhibition of lovastatin- and docosahexaenoic acid-initiated autophagy in triple negative breast cancer reverted resistance and enhanced cytotoxicity
Nahla E. El-Ashmawy et al.
LIFE SCIENCES (2020)
The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity
Rodolfo Chavez-Dominguez et al.
FRONTIERS IN ONCOLOGY (2020)
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Kirsten L. Bryant et al.
NATURE MEDICINE (2019)
STAT3 phosphorylation affects p53/p21 axis and KSHV lytic cycle activation
Roberta Santarelli et al.
VIROLOGY (2019)
Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells
Bowen Xie et al.
REDOX BIOLOGY (2019)
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
Sung-Hwan Moon et al.
CELL (2019)
Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis
Cheng-Wei Chou et al.
SCIENTIFIC REPORTS (2019)
The stiff RhoAd from mevalonate to mutant p53
Giovanni Sorrentino et al.
CELL DEATH AND DIFFERENTIATION (2018)
Primary effusion lymphoma: current perspectives
Mayur Narkhede et al.
ONCOTARGETS AND THERAPY (2018)
Activation of the SphK1/ERK/p-ERK pathway promotes autophagy in colon cancer cells
Chunyan Xu et al.
ONCOLOGY LETTERS (2018)
Marsdenia tenacissima extract induces apoptosis and suppresses autophagy through ERK activation in lung cancer cells
Yan-Na Jiao et al.
CANCER CELL INTERNATIONAL (2018)
Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer
Nagaraj S. Nagathihalli et al.
CANCER RESEARCH (2018)
The interplay between mutant p53 and the mevalonate pathway
Alejandro Parrales et al.
CELL DEATH AND DIFFERENTIATION (2018)
Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia
Austin B. Henslee et al.
BIOMARKER RESEARCH (2018)
Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells
Roberta Gonnella et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
Marisa Granato et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways
Marisa Granato et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells
Sin-Ting Wang et al.
CELL DEATH & DISEASE (2017)
Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation
Marisa Granato et al.
CELLULAR SIGNALLING (2017)
Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway
Tingting Wang et al.
ONCOTARGET (2016)
Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells
Marisa Granato et al.
CANCER LETTERS (2015)
Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression
Marisa Granato et al.
ONCOTARGET (2015)
Autophagy and apoptosis: where do they meet?
Subhadip Mukhopadhyay et al.
APOPTOSIS (2014)
ERKs in Cancer: Friends or Foes?
Xavier Deschenes-Simard et al.
CANCER RESEARCH (2014)
MEK1/2 Overactivation Can Promote Growth Arrest by Mediating ERK1/2-Dependent Phosphorylation of p70S6K
Jean-Philippe Guegan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
The opposite prognostic significance of nuclear and cytoplasmic p21 expression in resectable gastric cancer patients
Yefei Huang et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Erk1/2 activatiOn and modulation of STAT3 signaling in oral cancer
Ioannis Gkouveris et al.
ONCOLOGY REPORTS (2014)
Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
C. Kao et al.
CELL DEATH & DISEASE (2014)
Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53-survivin signaling cascade
Hang-Lung Chang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer
Ruiwu Liu et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Metabolic intervention on lipid synthesis converging pathways abrogates prostate cancer growth
V. Fritz et al.
ONCOGENE (2013)
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
William A. Freed-Pastor et al.
CELL (2012)
Statin-induced apoptosis via the suppression of ERK1/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma
Masashi Yanae et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas
Aadra P. Bhatt et al.
BLOOD (2010)
Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells
L. Sauer et al.
ONCOGENE (2010)
Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity
Elisabeth Corcelle et al.
CANCER RESEARCH (2006)
Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies
SA Holstein et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways
JC Chen et al.
CELLULAR SIGNALLING (2006)
Role of Stat3 in regulating p53 expression and function
GL Niu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma
Y Aoki et al.
BLOOD (2003)
Extracellular zinc stimulates ERK-dependent activation of p21Cip/WAF1 and inhibits proliferation of colorectal cancer cells
KS Park et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3
J Lin et al.
ONCOGENE (2002)
分享论文
